Shelter Pharma secures ₹50,347 order from Verka Dairy for vet supplements
Shelter Pharma Ltd announced a ₹50,347.50 order from Verka Dairy Ludhiana for veterinary feed supplements. The domestic deal, disclosed under SEBI LODR regulations, includes supplies of DIA-VET BLOUS and UTRON. Management views this as a positive indicator for future revenue growth and client confidence.

*this image is generated using AI for illustrative purposes only.
Shelter Pharma has secured a purchase order from Verka Dairy Ludhiana for the supply of veterinary feed supplements, marking a new business acquisition in the domestic market. The order, valued at ₹50,347.50, was received in the normal course of business on July 24, 2026. This engagement with Verka Dairies, the flagship brand of MILKFED Punjab, underscores growing demand for specialized veterinary inputs among major dairy cooperatives in North India.
The transaction is classified as a domestic order and does not involve any related party transactions or interests from the promoter group. Shelter Pharma’s Board highlighted that the award reflects the client's confidence in the company's ability to deliver quality solutions efficiently. The order is expected to contribute positively to the company's future revenues and overall business growth.
Order Details
The purchase order covers two specific veterinary feed supplement products. The financial breakdown and product specifications are detailed below:
| Product Name | Unit | Quantity | Unit Price (₹) | Total Value (₹) |
|---|---|---|---|---|
| DIA-VET BLOUS | NOS | 1000x17.20 | 17200.00 | |
| UTRON (For retention of Placenta/Ecbloic) | Each | 600x51.25 | 30750.00 | |
| Total | 50347.50 |
The company must execute the order within mutually agreed timelines as per the purchase order schedule. The products are intended for veterinary use within the dairy operations, specifically targeting animal health and productivity.
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was submitted to BSE Limited by Mustaqim Nisar Ahmed Sabugar, Managing Director of Shelter Pharma Limited. The filing confirms that the transaction is conducted at arm's length and falls outside the scope of related party transactions.
What the Numbers Show
While the absolute value of ₹50,347.50 is modest in the context of large-cap pharmaceutical contracts, the strategic significance lies in the client profile. Securing a contract with Verka Dairies, a major entity under MILKFED Punjab, validates Shelter Pharma’s product efficacy in a highly competitive regional market. For specialty chemical and veterinary input manufacturers, entry into the supply chain of large dairy cooperatives often serves as a gateway to recurring revenue streams, given the continuous need for animal health supplements. The absence of promoter interest ensures the transaction is purely commercial, reflecting organic demand rather than internal channeling.
Historical Stock Returns for Shelter Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.85% | +1.92% | -9.40% | -30.26% | -41.02% | -36.84% |
Will Shelter Pharma pursue similar contracts with other major dairy cooperatives across India to scale this new revenue stream?
How significant is the veterinary feed supplement segment expected to be in Shelter Pharma's overall revenue mix over the next fiscal year?
Does this order indicate a broader strategic shift for Shelter Pharma towards domestic agricultural and veterinary markets rather than just pharmaceuticals?


































